LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 32.28 | 770.25 | 3378 | 3392 | 0.9956 | 0.9959 | MN20160304_L02 | C08 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 32.28 | 770.25 | 3314 | 3392 | 0.9768 | 0.9781 | MN20160304_L02 | D15 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 34.50 | 770.25 | 3672 | 3712 | 0.9892 | 0.9905 | MN20160304_L02 | C08 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 34.50 | 770.25 | 3563 | 3712 | 0.9599 | 0.9642 | MN20160304_L02 | D15 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 36.73 | 770.25 | 4000 | 4086 | 0.9789 | 0.9824 | MN20160304_L02 | C08 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 36.73 | 770.25 | 3937 | 4086 | 0.9635 | 0.9694 | MN20160304_L02 | D15 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 38.95 | 770.25 | 4391 | 4543 | 0.9664 | 0.9735 | MN20160304_L02 | C08 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 38.95 | 770.25 | 4401 | 4543 | 0.9686 | 0.9752 | MN20160304_L02 | D15 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 41.17 | 770.25 | 4791 | 5010 | 0.9562 | 0.9671 | MN20160304_L02 | C08 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 41.17 | 770.25 | 4886 | 5010 | 0.9751 | 0.9814 | MN20160304_L02 | D15 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 43.39 | 770.25 | 5261 | 5404 | 0.9735 | 0.9810 | MN20160304_L02 | C08 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 43.39 | 770.25 | 5374 | 5404 | 0.9944 | 0.9960 | MN20160304_L02 | D15 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 45.61 | 770.25 | 5598 | 5813 | 0.9630 | 0.9743 | MN20160304_L02 | C08 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 45.61 | 770.25 | 5709 | 5813 | 0.9821 | 0.9877 | MN20160304_L02 | D15 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 47.83 | 770.25 | 5937 | 6223 | 0.9540 | 0.9690 | MN20160304_L02 | C08 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 47.83 | 770.25 | 6037 | 6223 | 0.9700 | 0.9799 | MN20160304_L02 | D15 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 50.05 | 770.25 | 6406 | 6629 | 0.9663 | 0.9780 | MN20160304_L02 | C08 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 50.05 | 770.25 | 6402 | 6629 | 0.9657 | 0.9776 | MN20160304_L02 | D15 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 52.27 | 770.25 | 6807 | 7058 | 0.9643 | 0.9774 | MN20160304_L02 | C08 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 52.27 | 770.25 | 6830 | 7058 | 0.9676 | 0.9795 | MN20160304_L02 | D15 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 54.49 | 770.25 | 7203 | 7555 | 0.9534 | 0.9712 | MN20160304_L02 | C08 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 54.49 | 770.25 | 7362 | 7555 | 0.9744 | 0.9843 | MN20160304_L02 | D15 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 56.71 | 770.25 | 7567 | 8001 | 0.9457 | 0.9672 | MN20160304_L02 | C08 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 56.71 | 770.25 | 7967 | 8001 | 0.9957 | 0.9974 | MN20160304_L02 | D15 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 58.94 | 770.25 | 8022 | 8444 | 0.9500 | 0.9705 | MN20160304_L02 | C08 |